Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
These statements have not been evaluated by the FDA
August 2, 2024: Comprehensive Data Analysis Suggests Rybelsus May Be Associated with an Increased Risk of Blood Clots, DVT, and Pulmonary Embolisms Trial data from an efficacy study point to an increased risk of blood clots for people taking semaglutide drugs, like Rybelsus, for type 2 diabetes
A 2.38-fold increase in hair count ratio versus 1.21 for placebo represents a clinically meaningful difference that patients would notice visually
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
While not specifically associated with semaglutide, any concerning skin changes warrant dermatologic evaluation
US$ 23.40
US$ 27.63
US$ 20.00
US$ 26.35
US$ 22.96
